11-32435168-C-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6BS2_Supporting

The NM_024426.6(WT1):​c.193G>A​(p.Gly65Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000245 in 1,521,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G65W) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00025 ( 0 hom. )

Consequence

WT1
NM_024426.6 missense

Scores

2
1
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:5

Conservation

PhyloP100: 1.75

Publications

1 publications found
Variant links:
Genes affected
WT1 (HGNC:12796): (WT1 transcription factor) This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015]
WT1-AS (HGNC:18135): (WT1 antisense RNA) This gene is located upstream of the Wilms tumor 1 (WT1) gene; these two genes are bi-directionally transcribed from the same promoter region. This gene is imprinted in kidney, with preferential expression from the paternal allele. Imprinting defects at chromosome 11p13 may contribute to tumorigenesis. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.039034307).
BP6
Variant 11-32435168-C-T is Benign according to our data. Variant chr11-32435168-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 241478.
BS2
High AC in GnomAd4 at 27 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024426.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WT1
NM_024426.6
MANE Select
c.193G>Ap.Gly65Arg
missense
Exon 1 of 10NP_077744.4
WT1
NM_024424.5
c.193G>Ap.Gly65Arg
missense
Exon 1 of 10NP_077742.3H0Y7K5
WT1
NM_001407044.1
c.193G>Ap.Gly65Arg
missense
Exon 1 of 10NP_001393973.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WT1
ENST00000452863.10
TSL:1 MANE Select
c.193G>Ap.Gly65Arg
missense
Exon 1 of 10ENSP00000415516.5P19544-7
WT1
ENST00000639563.4
TSL:1
c.193G>Ap.Gly65Arg
missense
Exon 1 of 9ENSP00000492269.3P19544-8
WT1
ENST00000332351.9
TSL:1
c.193G>Ap.Gly65Arg
missense
Exon 1 of 9ENSP00000331327.5J3KNN9

Frequencies

GnomAD3 genomes
AF:
0.000178
AC:
27
AN:
151996
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000233
AC:
28
AN:
120258
AF XY:
0.000226
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000433
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000555
Gnomad OTH exome
AF:
0.000541
GnomAD4 exome
AF:
0.000252
AC:
345
AN:
1369096
Hom.:
0
Cov.:
44
AF XY:
0.000248
AC XY:
167
AN XY:
674294
show subpopulations
African (AFR)
AF:
0.0000331
AC:
1
AN:
30222
American (AMR)
AF:
0.0000580
AC:
2
AN:
34494
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24486
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34742
South Asian (SAS)
AF:
0.0000128
AC:
1
AN:
78014
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33274
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4728
European-Non Finnish (NFE)
AF:
0.000310
AC:
332
AN:
1072156
Other (OTH)
AF:
0.000158
AC:
9
AN:
56980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
25
50
74
99
124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000178
AC:
27
AN:
151996
Hom.:
0
Cov.:
30
AF XY:
0.000162
AC XY:
12
AN XY:
74222
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41408
American (AMR)
AF:
0.0000655
AC:
1
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.000338
AC:
23
AN:
67970
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000428
Hom.:
0
Bravo
AF:
0.000178
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000144
AC:
1
ExAC
AF:
0.0000803
AC:
7

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
not provided (4)
-
-
1
11p partial monosomy syndrome;C0950121:Drash syndrome;C0950122:Frasier syndrome;CN033288:Wilms tumor 1 (1)
-
1
-
Hereditary cancer-predisposing syndrome (1)
-
-
1
Inborn genetic diseases (1)
-
1
-
Meacham syndrome (1)
-
1
-
Nephrotic syndrome, type 4 (1)
-
1
-
not specified (1)
-
1
-
Wilms tumor 1 (1)
-
1
-
WT1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
17
DANN
Benign
0.86
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.63
D
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.039
T
MetaSVM
Benign
-1.0
T
PhyloP100
1.7
PrimateAI
Pathogenic
0.80
T
PROVEAN
Benign
0.12
N
REVEL
Benign
0.026
Sift
Benign
0.12
T
Sift4G
Pathogenic
0.0010
D
Vest4
0.071
MutPred
0.12
Gain of MoRF binding (P = 0.0143)
MVP
0.092
ClinPred
0.16
T
GERP RS
0.49
PromoterAI
0.023
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374404615; hg19: chr11-32456714; API